The ImPAT Approach: Treating Pain Without Opioids

How can doctors offer relief to recovering addicts without using painkillers? A new study suggests that a hybrid of two psychosocial approaches could offer an alternative.

1:00 PM

Author | Kara Gavin

It's an unfortunate Catch-22: people trying to overcome addiction can't get treatment for pain because the most powerful pain medicines also carry an addiction risk.

SEE ALSO: Why U.S. Doctors Love Opioids and Hate Marijuana for Chronic Pain

In many cases, then, a patient's discomfort continues amid their addiction recovery — or they seek relief with the very substances they're trying to avoid.

A new study shows the potential of a non-drug, low-cost approach that combines behavioral therapy and social support to facilitate pain management without medication.

Just 10 weekly sessions of a new approach known as ImPAT (Improving Pain during Addiction Treatment) had noticeable effects in 55 participating veterans, according to results published in the journal Addiction by a team from the VA Center for Clinical Management Research in Ann Arbor and the University of Michigan Addiction Center.

Veterans who received ImPAT care in combination with addiction treatment reported a decrease both in overall pain levels and alcohol intake — as well as an increase in function — compared to veterans that received a less-focused approach (peer-support groups led by a therapist). 

Because both parties were receiving addiction treatment, drug use declined similarly.

"These results highlight the need for addiction treatment programs to offer a multifaceted approach that doesn't only address substance use but also the other factors that might be driving substance use, including pain," says Mark Ilgen, Ph.D., the study's lead author and a VA and U-M psychologist specializing in addiction research.

"We've shown that it's possible to improve pain outcomes in people with addiction and even have some spillover effects on their substance use."

We've shown that it's possible to improve pain outcomes in people with addiction and even have some spillover effects on their substance use.
Mark Ilgen, Ph.D.

Caught in the middle

All 129 patients in the study, most of them men in their 40s and 50s, already were receiving outpatient addiction treatment at the Ann Arbor VA.

But addiction treatment programs, Ilgen says, often have patients who suffer from chronic pain but offer few options or providers trained to treat them.

SEE ALSO: For Veterans With PTSD, Mindfulness Training Shows Promise

To make matters worse, he notes, "Past studies of psychosocial approaches for pain have often excluded people with drug or alcohol problems."

Which is why the sharp rise in opioid addiction in recent years — often among people who started taking the painkillers as treatment for acute or chronic pain — has made the search for effective non-drug pain treatment options even more urgent.

"Long-term use of opioids can sometimes lead to a hypersensitivity to pain, so there may actually be a causal link between use of these medications and pain," says Ilgen, also an associate professor of psychiatry and a member of the U-M Institute for Healthcare Policy and Innovation. "We need to study psychological pain management approaches in opioid-dependent patients, including those receiving addiction therapies such as buprenorphine."

A collaborative approach

By combining elements of cognitive behavioral therapy with another psychosocial approach called acceptance and commitment therapy, the ImPAT technique seeks to use integrated approaches to help patients fixate less on their pain and more on other aspects of life.

"We want to take the focus off pain and put it onto functioning and finding pleasurable ways to spend time," Ilgen says. "There's also a strong link between depression and pain. Pain is responsive to mood and mood is responsive to social support."

In an editorial accompanying the new paper, another addiction and pain specialist, William C. Becker, Ph.D. of Yale University and the Connecticut VA, notes that the new results are impressive — particularly because ImPAT was compared with another psychosocial approach.

And there is room to grow. The paper's researchers, including the U-M Addiction Center director and senior author Frederic Blow, Ph.D, have already launched a follow-up study in a larger group of 480 non-veterans in a residential addiction treatment program.

ImPAT, they note, has the potential to be easily and inexpensively adopted by addiction treatment centers and groups worldwide.

More Articles About: Rounds Addiction and Substance Abuse chronic pain Pain management
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of health care news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]


Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Featured News & Stories Naloxone in a bag
Health Lab
This Drug Could Save Their Lives, But Less Than 2% Get It
Prescribing guidelines recommend the opioid overdose rescue drug naloxone for anyone taking high-dose prescription opioids, overdose survivors and people with opioid addiction. A new study shows few receive it.
Car key and a marijuana cigarette laying on cannabis leaves
Health Lab
More Than Half of People Taking Cannabis for Chronic Pain Report Driving While High
New study finds worrisome statistics around medical cannabis users operating vehicles
pills spilling out of bottle
Health Lab
Primary care physicians are hesitant to accept chronic pain patients using opioids or cannabis
Michigan Medicine research finds that patients with chronic pain who use either substance may find it harder to find primary care physician than those who don’t.
Nociplastic pain researchers Chelsea Kaplan, Steven Harte, Andrew Schrepf, Dan Clauw
Department News
What we know about nociplastic pain
A new review article shines light on nociplastic pain, a type of pain some thought to be ‘all in your head’
Health Lab Podcast in brackets with a background with a dark blue translucent layers over cells
Health Lab Podcast
Presenting: The Fundamentals
Today on Health Lab, we are sharing an episode of The Fundamentals, another podcast from the Michigan Medicine Podcast Network that just launched its second season earlier this month. On this episode of The Fundamentals: "Cannabis and psychedelics: stigmatized substances or powerful therapeutics?" Dr. Kevin Boehnke talks about cannabis, psychedelics, and the increasing body of evidence for their legitimization as therapeutics.
mushrooms in a microscope
Health Lab
How cannabis and psilocybin might help some of the 50 million Americans experiencing chronic pain
Recent developments represent a dramatic change from long standing federal policy around these substances that has historically criminalized their use and blocked or delayed research efforts into their therapeutic potential.